Scholar Rock is a clinical-stage biopharmaceutical company.
51 - 200
π° $205M Post-IPO Equity on 2022-06
August 8
π‘ Remote β Anywhere in California
β° Full Time
π΄ Lead
π€ Sales
June 21
π Senior
π Compliance